Raymond W. Klecker

2.8k total citations
41 papers, 2.4k citations indexed

About

Raymond W. Klecker is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Raymond W. Klecker has authored 41 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Infectious Diseases. Recurrent topics in Raymond W. Klecker's work include HIV/AIDS drug development and treatment (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Cancer Treatment and Pharmacology (7 papers). Raymond W. Klecker is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Cancer Treatment and Pharmacology (7 papers). Raymond W. Klecker collaborates with scholars based in United States, Malaysia and India. Raymond W. Klecker's co-authors include Jerry M. Collins, Charles E. Myers, Samuel Broder, Robert Yarchoan, Robert C. Young, Robert F. Ozols, Thomas C. Hamilton, Alfred M. Rogan, Rose V. Thomas and Jean Jenkins and has published in prestigious journals such as Science, Biochemistry and Annals of Neurology.

In The Last Decade

Raymond W. Klecker

40 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raymond W. Klecker United States	23	848	810	489	311	286	41	2.4k
Andrew Gibson United States	28	330 0.4×	789 1.0×	275 0.6×	285 0.9×	352 1.2×	86	3.3k
Anil Tulpule United States	33	2.6k 3.1×	1.6k 2.0×	365 0.7×	154 0.5×	340 1.2×	93	4.6k
Steven G. Nadler United States	38	587 0.7×	1.5k 1.9×	153 0.3×	128 0.4×	237 0.8×	87	3.8k
Sigrid Hatse Belgium	36	1.8k 2.1×	1.5k 1.8×	631 1.3×	711 2.3×	361 1.3×	97	4.1k
Naoyuki Kanzaki Japan	27	646 0.8×	1.2k 1.4×	462 0.9×	717 2.3×	137 0.5×	47	2.9k
Minya Pu United States	29	674 0.8×	646 0.8×	165 0.3×	161 0.5×	259 0.9×	74	2.4k
Carol Cardarelli United States	23	3.0k 3.5×	1.9k 2.4×	882 1.8×	213 0.7×	271 0.9×	32	4.2k
Daniel F. Hoth United States	23	669 0.8×	528 0.7×	231 0.5×	229 0.7×	179 0.6×	56	1.8k
Ross Davey Australia	21	730 0.9×	802 1.0×	236 0.5×	127 0.4×	85 0.3×	43	1.7k
T Spector United States	22	638 0.8×	731 0.9×	423 0.9×	280 0.9×	668 2.3×	45	1.9k

Countries citing papers authored by Raymond W. Klecker

Since Specialization

Citations

This map shows the geographic impact of Raymond W. Klecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond W. Klecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond W. Klecker more than expected).

Fields of papers citing papers by Raymond W. Klecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond W. Klecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond W. Klecker. The network helps show where Raymond W. Klecker may publish in the future.

Co-authorship network of co-authors of Raymond W. Klecker

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond W. Klecker. A scholar is included among the top collaborators of Raymond W. Klecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond W. Klecker. Raymond W. Klecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kummar, Shivaani, Martin Gutierrez, Lawrence W. Anderson, et al.. (2013). Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas. Cancer Chemotherapy and Pharmacology. 72(4). 917–923. 14 indexed citations

Klecker, Raymond W., Richard L. Cysyk, & Jerry M. Collins. (2005). Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: Influence of sex and inhibitors. Bioorganic & Medicinal Chemistry. 14(1). 62–66. 49 indexed citations

Anderson, Lawrence W., Jerry M. Collins, Raymond W. Klecker, et al.. (2005). Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions. Cancer Chemotherapy and Pharmacology. 56(4). 351–357. 21 indexed citations

Cantilena, Louis R., Aspandiar G. Katki, Raymond W. Klecker, & Jerry M. Collins. (2004). Metabolism by N‐Acetyltransferase 1 In Vitro and in Healthy Volunteers: A Prototype for Targeted Inhibition. The Journal of Clinical Pharmacology. 44(12). 1405–1411. 2 indexed citations

Eiseman, Julie L., Paul E. Kinahan, Jerry M. Collins, et al.. (2004). Distribution of 1-(2-Deoxy-2-fluoro-β-d-arabinofuranosyl) Uracil in Mice Bearing Colorectal Cancer Xenografts. Clinical Cancer Research. 10(19). 6669–6676. 13 indexed citations

Klecker, Raymond W. & Jerry M. Collins. (2001). Thymidine phosphorylase as a target for imaging and therapy with thymine analogs. Cancer Chemotherapy and Pharmacology. 48(5). 407–412. 8 indexed citations

Klecker, Raymond W. & Jerry M. Collins. (1997). Stereoselective Metabolism of Fenoldopam and Its Metabolites in Human Liver Microsomes, Cytosol, and Slices. Journal of Cardiovascular Pharmacology. 30(1). 69–74. 8 indexed citations

Jamis‐Dow, Carlos, Raymond W. Klecker, Aspandiar G. Katki, & Jerry M. Collins. (1995). Metabolism of taxol by human and rat liver in vitro: A screen for drug interactions and interspecies differences. Cancer Chemotherapy and Pharmacology. 36(2). 107–114. 51 indexed citations

Seidman, Andrew D., Larry Norton, Bonnie Reichman, et al.. (1994). Taxol (Paclitaxel) plus Recombinant Human Granulocyte Colony-Stimulating Factor in the Treatment of Metastatic Breast Cancer. Oncology. 51(1). 33–39. 2 indexed citations

10.

Takimoto, Chris H., Raymond W. Klecker, William L. Dahut, et al.. (1994). Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 655(1). 97–104. 55 indexed citations

11.

Fang, Fang, Shakeel Ahmad, Jun Lei, et al.. (1993). Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells. Biochemistry. 32(27). 6995–7001. 12 indexed citations

12.

Jamis‐Dow, Carlos, Raymond W. Klecker, Gisele Sarosy, Eddie Reed, & Jerry M. Collins. (1993). Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer. Cancer Chemotherapy and Pharmacology. 33(1). 48–52. 60 indexed citations

13.

Speth, P A, Timothy J. Kinsella, Alfred E. Chang, et al.. (1989). Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: As a radiosensitizer and as a marker for cell kinetic studies. International Journal of Radiation Oncology*Biology*Physics. 16(5). 1247–1250. 24 indexed citations

14.

Klecker, Raymond W., Jerry M. Collins, Robert Yarchoan, et al.. (1988). Pharmacokinetics of 2‘,3’‐Dideoxycytidine in Patients with AIDS and Related Disorders. The Journal of Clinical Pharmacology. 28(9). 837–842. 90 indexed citations

15.

Yarchoan, Robert, Rose V. Thomas, Jordan Grafman, et al.. (1988). Long-term administration of 3?-Azido-2?,3?-dideoxythymidine to patients with AIDS-related neurological disease. Annals of Neurology. 23(S1). S82–S87. 72 indexed citations

16.

Speth, P A, Timothy J. Kinsella, Alfred E. Chang, et al.. (1988). Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver. Clinical Pharmacology & Therapeutics. 44(4). 369–375. 35 indexed citations

17.

Bélanger, Karl, Jerry M. Collins, & Raymond W. Klecker. (1987). Technique for detection of DNA nucleobases by reversed-phase high-performance liquid chromatography optimized for quantitative determination of thymidine substitution by iododeoxyuridine. Journal of Chromatography B Biomedical Sciences and Applications. 417(1). 57–63. 24 indexed citations

18.

Bélanger, Karl, et al.. (1986). Incorporation of iododeoxyuridine into DNA of granulocytes in patients.. PubMed. 46(12 Pt 1). 6509–12. 22 indexed citations

19.

Cunnion, Robert E., Robert F. Ozols, Sebastian T. Palmeri, et al.. (1986). CARDIAC EFFECTS OF SUPRAPHARMACOLOGIC DOSES OF VERAPAMIL. Critical Care Medicine. 14(4). 397–397.

20.

Klecker, Raymond W., Jean Jenkins, Timothy J. Kinsella, et al.. (1985). Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clinical Pharmacology & Therapeutics. 38(1). 45–51. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact